LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline KPTI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction CXDO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix Cresud CRESY Q1 2026 Earnings Strong EPS Report Despite Modest Stock Decline